ClinicalTrials.gg
RecruitingNCT06459154Updated Jun 14, 2024

The Effectiveness of Mixed Reality as Interventional Tool for the Improvement on Quality of Life for People With Parkinson´s Disease.

An interventional study of Mixed Reality and Traditional Physiotherapy in Parkinson Disease, sponsored by University of Nicosia. Recruiting at 1 site in Cyprus. Open to participants aged 60 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-14.

Sponsored by University of Nicosia · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Feb 2025, 1 year 8 months ago, but the record still lists the study as recruiting.
  • Registered 8 months after the study started (first participant enrolled Aug 2023, registered May 2024).
  • Started Aug 2023; still recruiting 3 years 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
60 Years to 100 Years
Sex
All
01

Study summary

Parkinson's disease is a chronic, neurodegenerative disease of unknown cause, affecting elderly people over the age of 60. It is the second most common neurodegenerative disease, presenting psychomotor signs and symptoms that lead to impaired functionality and quality of life in affected individuals. Mixed reality involves the delivery of digital stimuli in real time and space through spatial mapping using glasses, safely providing multiple iterations to carry out daily activities.

Through this tool and in collaboration with technologically skilled mixed reality developers, the software for the rehabilitation program to be applied to Parkinson's disease patients was also developed.

The main objective of this clinical study is to examine the effect of a mixed reality program compared to a traditional physiotherapy program on quality of life and motivation for the participation of people with Parkinson's disease.

Read the detailed description

Parkinson's disease is a chronic, neurodegenerative disease of unknown cause, affecting elderly people over the age of 60. It is the second most common neurodegenerative disease, presenting psychomotor signs and symptoms that lead to impaired functioning and quality of life in affected individuals. Mixed reality involves the delivery of digital stimuli in real time and space through spatial mapping using glasses, safely providing multiple iterations to carry out daily activities.

Through this tool and in collaboration with technologically skilled mixed reality developers, the software for the rehabilitation program to be applied to Parkinson's disease patients was also developed.

The main objective of this clinical study is to examine the effect of a mixed reality program compared to a traditional physiotherapy program on quality of life and motivation for the participation for people with Parkinson's disease.

The study will be divided into two phases, the first of which includes the translation and adaptation of the Intrinsic Motivation Inventory (IMI) questionnaire, which assesses motivation and is not available in Greek, and will be used in 300 healthy subjects to assess its psychometric characteristics.

The second phase of the clinical trial is a parallel, blinded, randomized study involving 45 patients.

This study will provide the opportunity to use innovative equipment that offers multiple stimuli increasing the interactivity of the participants to perform functional activities. This research is the first clinical study in Cyprus that will apply the reported rehabilitation tool aiming to improve and evaluate the quality of life, functionality and motivation of people with Parkinson's disease. Moreover, it enables the development of cognitive and motor rehabilitation by increasing the interaction of the individual with the environment and facilitating the completion of treatment goals.

The research using mixed reality and through a comparative process with traditional physiotherapy, aims to provide valid and reliable data to the general public and health scientists, facilitating the selection of appropriate means to provide a holistic treatment plan.

Translated with DeepL.com (free version)

02

Conditions studied

  • Parkinson Disease

Browse trials for

Keywords

  • PD
  • Mixed Reality
  • Physiotherapy
  • QOL
  • Motivation
03

In context

Parkinson Disease

4,573 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

This study's planned enrollment of 15 is below the median of 40 across 3,353 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

University of Nicosia is the lead sponsor of 6 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

For the first interventional phase:

Inclusion Criteria:

  1. Male and female over 18 years old 2. Persons with independent gait 3. Normal cognitive ability 5. Greek Native language

Exclusion Criteria:

  1. Presence of neurological disease
  2. Presence of uncontrolled diseases of the circulatory system
  3. History of musculoskeletal surgery in the last 6 months
  4. Use of a walking aid
  5. Partial or total blindness

For the second interventional phase:

Inclusion Criteria:

  1. Male and female over 60 years old
  2. Persons with independent gait
  3. Normal cognitive ability
  1. Greek Native language

Exclusion Criteria:

  1. Presence of neurological disease
  2. Presence of uncontrolled diseases of the circulatory system
  3. History of musculoskeletal surgery in the last 6 months
  4. Use of a walking aid
  5. Partial or total blindness
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Mixed Reality interventional Group

    Other: Mixed Reality · Other: Traditional Physiotherapy

  • Experimental
    Traditional Physiotherapy Group

    Other: Mixed Reality · Other: Traditional Physiotherapy

  • Placebo comparator
    Placebo group

    Other: Mixed Reality · Other: Traditional Physiotherapy

Interventions

  • OtherMixed Reality

    The experimental group MR will use the mixed reality project involving activities in a supermarket. MR HoloLens2 glasses will be used to conduct the program. The technological equipment that will be used will allow the provision of visual and auditory stimuli. The program presents 5-10 different objects found in a supermarket, where you need, as you walk, to collect them within a mixed environment. This program offers coordination activities, posture, cognitive activities and balance exercises. The mixed reality program lasts 30 minutes, with a frequency of 3 times a week for 12 weeks.

  • OtherTraditional Physiotherapy

    The group of traditional physiotherapy follows the guidelines of EPDA. Specifically, the program will be 35-40 minutes long, 3 times a week for 12 weeks. The program includes 5 minutes warm up, 10 minutes resistance exercises, 10 minutes of balance exercises and stretching.

06

What researchers measure

Primary outcomes

  1. EuroQol 5 Dimension 5 Level

    Measurement of quality of life. Likert scoring style (1-5) where higher scores represent worse state of quality of life

    Time frame: baseline, 4weeks follow up

  2. The Short Form (12) Health Survey

    Measurement of quality of life: The scores ranged from 0 to 100, where higher scores representing better quality of life

    Time frame: baseline, 4weeks follow up

Secondary outcomes

  1. Intrinsic Motivation Inventory

    Measurement of intrinsic motivation: That contains 7 subcategories with average score from 1 to 7. Higher scores indicating better motivation

    Time frame: baseline, 4weeks follow up

  2. Mini Balance Evaluation Systems Test

    Measurement of functionality and Balance: The scale's scores ranging from 0 to 28, where higher scores represent better functionality

    Time frame: baseline, 4weeks follow up

  3. Multidirectional Reach Test

    Measurement of balance and functionality: Is the only scale that includes cm for the measurement of distance. Most healthy people present 25cm. People who present less than 18cm, indicates limitations on functional balance

    Time frame: baseline, 4weeks follow up

  4. Nine-Hole Peg Test

    Measurement of fine motor skills and functionality: The test scores are based on the average duration of four trials. Healthy females present 17.9-19.6 second and males 19-20.6 seconds. Higher average duration indicates limited fine mobility

    Time frame: baseline, 4weeks follow up

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2023 (actual). Primary completion is estimated for Feb 2025, 18 months after the start.

Of 1,291 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 18 months is below that.

Counting every sponsor, half of 1,367 studies reached it within 25 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
May 15, 2024
First posted
Jun 14, 2024
StartActual
Aug 20, 2023
Primary completionEst.
Feb 20, 2025
CompletionEst.
Dec 20, 2025
Last update
Jun 14, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 14, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06459154
Lead sponsor
University of Nicosia
Responsible party
Elena Papamichael (PhD Candidate in Physiotherapy, University of Nicosia) — Principal investigator
First posted
Jun 14, 2024
Start date
Aug 20, 2023
Primary completion
Feb 20, 2025 (estimated)
Completion
Dec 20, 2025 (estimated)
Last update
Jun 14, 2024

Study contacts

Elena Papamichael, PhD Cand
Contact
papamichael.e1@live.unic.ac.cy
99886346 ext. 00357
Elena Papamichael, PhD Cand
principal investigator · University of Nicosia

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion